Y. Kiyan

发表

oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway

H. Haller, I. Dumler, D. Dawodu, 2019, Molecular Biology Reports.

Vascular Aging: Revealing the Role and Clinical Perspectives of the Urokinase System

H. Haller, B. Fuhrman, I. Dumler, 2014 .

Urokinase Receptor Associates With Myocardin to Control Vascular Smooth Muscle Cells Phenotype in Vascular Disease

B. Chichkov, A. Ovsianikov, H. Haller, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Urokinase Receptor Mediates Doxorubicin-Induced Vascular Smooth Muscle Cell Senescence via Proteasomal Degradation of TRF2

H. Haller, M. Hodjat, I. Dumler, 2012, Journal of Vascular Research.

Protein kinase C beta deficiency increases glucose-mediated peritoneal damage via M1 macrophage polarization and up-regulation of mesothelial protein kinase C alpha.

Lei Dong, S. Rong, H. Haller, 2018, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Urokinase receptor associates with TLR4 interactome to promote LPS response

H. Haller, S. Tkachuk, P. Ragno, 2020, bioRxiv.

Urokinase receptor mediates mobilization, migration, and differentiation of mesenchymal stem cells.

H. Haller, G. Eden, Krishna C. Vallabhaneni, 2011, Cardiovascular research.

Effects of therapeutic plasma exchange on the endothelial glycocalyx in septic shock

T. Welte, Julius J Schmidt, H. Haller, 2021, Intensive Care Medicine Experimental.

In peripartum cardiomyopathy Plasminogen Activator Inhibitor-1 is a potential new biomarker with controversial roles.

J. Bauersachs, D. Hilfiker-Kleiner, T. Thum, 2019, Cardiovascular research.

Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19

T. Welte, H. Haller, M. Hoeper, 2020, American journal of respiratory and critical care medicine.

Urokinase-Type Plasminogen Activator Downregulates Paraoxonase 1 Expression in Hepatocytes by Stimulating Peroxisome Proliferator–Activated Receptor-&ggr; Nuclear Export

M. Aviram, B. Fuhrman, I. Dumler, 2012, Arteriosclerosis, thrombosis, and vascular biology.

Calcium dobesilate reduces SARS-CoV-2 entry into endothelial cells by inhibiting virus binding to heparan sulfate

S. Rong, H. Haller, N. Shushakova, 2022, Scientific Reports.

Dual Inhibition of Classical Protein Kinase C-α and Protein Kinase C-β Isoforms Protects Against Experimental Murine Diabetic Nephropathy

H. Haller, M. Meier, Joon-Keun Park, 2013, Diabetes.

oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion

H. Haller, J. Hegermann, I. Dumler, 2018, Scientific Reports.

oxLDL inhibits differentiation of mesenchymal stem cells into osteoblasts via the CD36 mediated suppression of Wnt signaling pathway

H. Haller, I. Dumler, Margret Patecki, 2019, Molecular Biology Reports.

Heparanase-2 protects from LPS-mediated endothelial injury by inhibiting TLR4 signalling

B. Chichkov, H. Haller, R. Kiyan, 2019, Scientific Reports.

Urokinase Receptor Counteracts Vascular Smooth Muscle Cell Functional Changes Induced by Surface Topography

B. Chichkov, H. Haller, R. Kiyan, 2013, Theranostics.

TLR4 Response to LPS Is Reinforced by Urokinase Receptor

S. Rong, H. Haller, P. Ragno, 2020, Frontiers in Immunology.

Urokinase Receptor Mediates Osteoclastogenesis via M‐CSF Release From Osteoblasts and the c‐Fms/PI3K/Akt/NF‐κB Pathway in Osteoclasts

H. Haller, I. Dumler, Margret Patecki, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Transcriptomic pathway analysis of urokinase receptor silenced breast cancer cells: a microarray study

K. Acharya, H. Haller, I. Dumler, 2017, Oncotarget.

Loss of Urokinase Receptor Sensitizes Cells to DNA Damage and Delays DNA Repair

H. Haller, M. Hodjat, I. Dumler, 2014, PloS one.

oxLDL induces inflammatory responses in vascular smooth muscle cells via urokinase receptor association with CD36 and TLR4.

H. Haller, D. Hilfiker-Kleiner, B. Fuhrman, 2014, Journal of molecular and cellular cardiology.

Proof-of-Concept Study of Drug Brain Permeability Between in Vivo Human Brain and an in Vitro iPSCs-Human Blood-Brain Barrier Model

O. Langer, A. Pruvost, N. Costa, 2019, Scientific Reports.

CHK1 and RAD51 activation after DNA damage is regulated via urokinase receptor/TLR4 signaling

H. Haller, I. Dumler, Y. Kiyan, 2016, Cell Death and Disease.

oxLDL inhibits differentiation and functional activity of osteoclasts via scavenger receptor-A mediated autophagy and cathepsin K secretion

H. Haller, J. Hegermann, I. Dumler, 2018, Scientific Reports.

Heparanase-2 protects from endothelial injury by inhibiting TLR4 signaling

B. Chichkov, H. Haller, R. Kiyan, 2019, bioRxiv.

Vascular Aging: Revealing the Role and Clinical Perspectives of the Urokinase System

Y. Kiyan, Inna Dumler, Bianca Fuhrman, 2017 .

Urokinase Receptor Mediates Doxorubicin-Induced Vascular Smooth Muscle Cell Senescence via Proteasomal Degradation of TRF2

H. Haller, M. Hodjat, I. Dumler, 2012, Journal of Vascular Research.